Apixaban (CAS 503612-47-3): A Key Pharmaceutical Intermediate for Anticoagulant Research
Apixaban, known by its CAS number 503612-47-3, is more than just a therapeutic drug; it is a vital pharmaceutical intermediate and research chemical. Its precise mechanism as a direct Factor Xa inhibitor makes it invaluable for researchers studying coagulation pathways, drug interactions, and developing new anticoagulation strategies. NINGBO INNO PHARMCHEM CO.,LTD. provides high-purity Apixaban API, supporting crucial advancements in pharmaceutical research and development.
The chemical structure and biological activity of Apixaban make it an ideal compound for in vitro and in vivo studies. Researchers utilize Apixaban to investigate the downstream effects of Factor Xa inhibition on thrombin generation, platelet function, and overall hemostasis. Understanding these complex interactions is key to developing more targeted and effective antithrombotic therapies. The availability of reliable Apixaban API from NINGBO INNO PHARMCHEM CO.,LTD. ensures that scientific investigations can proceed with confidence in the purity and consistency of the material.
As a pharmaceutical intermediate, Apixaban serves as a building block for further chemical synthesis or formulation development. Pharmaceutical companies often require bulk quantities of high-quality Apixaban API to conduct preclinical and clinical trials, or for the commercial production of anticoagulant medications. NINGBO INNO PHARMCHEM CO.,LTD. addresses this need by offering Apixaban API that adheres to stringent quality control measures, facilitating seamless integration into complex manufacturing processes.
The research landscape constantly seeks new insights into cardiovascular diseases and thrombotic disorders. Apixaban, as a well-established and potent Factor Xa inhibitor, provides a critical reference point and tool for such investigations. By supplying Apixaban, NINGBO INNO PHARMCHEM CO.,LTD. actively supports the scientific community in pushing the boundaries of anticoagulant research, contributing to the development of next-generation treatments.
In essence, Apixaban (CAS 503612-47-3) is a cornerstone in both clinical treatment and pharmaceutical research. Its role as a direct Factor Xa inhibitor is critical, and its availability as a high-quality API from suppliers like NINGBO INNO PHARMCHEM CO.,LTD. is fundamental for continued innovation in anticoagulation therapy and related medical fields.
Perspectives & Insights
Bio Analyst 88
“Its precise mechanism as a direct Factor Xa inhibitor makes it invaluable for researchers studying coagulation pathways, drug interactions, and developing new anticoagulation strategies.”
Nano Seeker Pro
“provides high-purity Apixaban API, supporting crucial advancements in pharmaceutical research and development.”
Data Reader 7
“The chemical structure and biological activity of Apixaban make it an ideal compound for in vitro and in vivo studies.”